Table 2.
Frequency of metabolic diseases* in women from the SABC study, overall and by case/control status
| Metabolic diseases, n | Total (N=798), n (%) | Breast cancer (N=399), n (%) | Controls (N=399), n (%) | p-value |
|---|---|---|---|---|
| 0 | 72 (9.0) | 42 (10.5) | 30 (7.5) | 0.285 |
| 1 | 192 (24.1) | 101 (25.3) | 91 (22.8) | |
| 2 | 304 (38.1) | 139 (34.9) | 165 (41.3) | |
| 3 | 197 (24.7) | 99 (24.8) | 98 (24.6) | |
| 4 | 33 (4.1) | 18 (4.5) | 15 (3.8) | |
| Total | 798 (100) | 399 (100) | 399 (100) |
SABC = South Africa Breast Cancer.
*
Defined as obesity (body mass index ≥30 kg/m2), dyslipidaemia (total cholesterol >6.21 mmol/L), hypertension (blood pressure ≥140/≥90 mmHg or medication use) and hyperglycaemia (fasting glucose >5.5 mmol/L).